Literature DB >> 11707650

Modification of the sensitivity to cisplatin with c-myc over-expression or down-regulation in colon cancer cells.

T Funato1, K Kozawa, M Kaku, T Sasaki.   

Abstract

Human colon cancer SW480 cells express the c-myc gene. On the other hand, SW480DDP cell lines resistant to cisplatin exhibited decreased c-myc gene expression, but their cell growth rates remained similar to those of their parental cells. Antisense oligonucleotides to c-myc inhibited c-myc expression and induced increased resistance to cisplatin in SW480 cells. In contrast, SW480DDP cells showed increased c-myc expression and reversed sensitivity to cisplatin when these cells were transfected with c-myc cDNA from the pLNCX plasmid. Moreover, SW480DDP cells transfected with c-myc cDNA induced apoptosis when exposed to cisplatin, but not SW480 cells transfected with an antisense sequence for c-myc. Transfection either with a c-myc antisense sequence or c-myc cDNA to these cells did not change their growth rates. Thus enforced expression of c-myc in SW480 and SW620 lines sensitizes cells to cisplatin-induced apoptosis, whereas the down-regulation of c-myc in SW480DDP and SW620DDP increases cisplatin resistance when using antisense strategy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11707650     DOI: 10.1097/00001813-200111000-00006

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  1 in total

1.  Anticancer response to disulfiram may be enhanced by co-treatment with MEK inhibitor or oxaliplatin: modulation by tetrathiomolybdate, KRAS/BRAF mutations and c-MYC/p53 status.

Authors:  Ali Calderon-Aparicio; Alejandro Cornejo; Andrea Orue; Manuel Rieber
Journal:  Ecancermedicalscience       Date:  2019-01-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.